Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Disease Progression and GGH[original query] |
---|
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin. Lung cancer (Amsterdam, Netherlands) 2012 Oct 78 (1): 92-9. Tiseo Marcello, Giovannetti Elisa, Tibaldi Carmelo, Camerini Andrea, Di Costanzo Francesco, Barbieri Fausto, Burgers Jacobus A, Vincent Andrew, Peters Godefridus J, Smit Egbert F, Ardizzoni Andr |
Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations. The pharmacogenomics journal 2014 Oct 14 (5): 411-7. Corrigan A, Walker J L, Wickramasinghe S, Hernandez M A, Newhouse S J, Folarin A A, Lewis C M, Sanderson J D, Spicer J, Marinaki A |
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular cancer therapeutics 2019 Oct . Malhotra Usha, Mukherjee Sarbajit, Fountzilas Christos, Boland Patrick, Miller Austin, Patnaik Santosh, Attwood Kristopher, Yendamuri Sai, Adjei Araba, Kannisto Eric, Opyrchal Mateusz, Bushunow Peter, Loud Peter, Iyer Renuka, Khushalani Nikh |
- Page last reviewed:Feb 1, 2024
- Content source: